PTCT

#2358
PTC Therapeutics, Inc. - Common Stock
73.8 5 USD
+3.94%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
73.85
73.85
Jahresspanne
44.17
87.50
Tagesänderung
+3.94%
Monatliche Änderung
+13.98%
6 month change
-11.23%
Jahresänderung
+50.99%
Vorheriger Schlusskurs
71.0 5
Open
73.8 5
Tief
73.8 5
High
73.8 5
Volumen
158
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

PTC Therapeutics, Inc. - Common Stock

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

Nachrichten